Now Available: Jordan Pharmaceuticals & Healthcare Report Q2 2014
Jordan is a moderately attractive pharmaceutical market in the Middle East and Africa (MEA) region. However, despite a number of positive factors, we highlight current cutbacks in government spending, which have directly impacted the pharmaceutical market (medicine price cuts of 10-74% in 2013), as a key concern to drugmakers. We warn that additional government measures could include a slowdown or reduction in medicines import growth, which, given the country's reliance on high-value medicines, will negatively impact multinationals that export to...
View full press release